John K. Wiencke, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
John K. Wiencke, PhD

Professor, Department of Neurological Surgery, and Co-Director, Division of Epidemiology, UCSF
Robert Magnin Newman Endowed Chair in Neuro-oncology, UCSF

john.wiencke@ucsf.edu

Phone: (415) 476-3059 (voice)
Box 0560, UCSF
San Francisco, CA 94143-0560

View on UCSF Profiles

Cancer Center Membership

Program Member ยป Cancer Genetics

Education

University of Minnesota, Minneapolis, MN, B.S., 1976, Biology
University of Minnesota, Minneapolis, MN, M.S., 1978, Environmental Health
University of Minnesota, Minneapolis, MN, Ph.D., 1983, Pathology


Professional Experience

  • 1983-1986
    UCSF, Laboratory of Radiobiology and Environmental Health, Postdoctoral Fellow
  • 1986-1989
    UCSF, Epidemiology & Biostatistics, Assistant Research Geneticist
  • 1986-1995
    UCSF, Laboratory of Radiobiology and Environmental Health, Research Associate
  • 1990-1993
    UCSF, Epidemiology & Biostatistics, Assistant Adjunct Professor
  • 1990-present
    UCSF, Epidemiology & Biostatistics, Director, Molecular Epidemiology Laboratory
  • 1993-1999
    UCSF, Epidemiology & Biostatistics, Associate Adjunct Professor
  • 1995-present
    UCSF, Epidemiology & Biostatistics, Director, Molecular Epidemiology Program
  • 1999-2002
    UCSF, Epidemiology & Biostatistics, Adjunct Professor
  • 1999-2006
    Harvard School of Public Health, Department of Cancer Cell Biology, Visiting Lecturer
  • 2002-2004
    UCSF, Epidemiology & Biostatistics, Professor in Residence
  • 2004-present
    UCSF, Dept of Neurological Surgery, Co-Director Division of Epidemiology

Selected Publications

  1. Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk. Oncotarget. 2015 Dec 4.
    View on PubMed
  2. Somatic Mutation Allelic Ratio Test Using ddPCR (SMART-ddPCR): An Accurate Method for Assessment of Preferential Allelic Imbalance in Tumor DNA. PLoS One. 2015; 10(11):e0143343.
    View on PubMed
  3. A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution. Cancer Res. 2015 Nov 2.
    View on PubMed
  4. Understanding the Role of the Immune System in the Development of Cancer: New Opportunities for Population-Based Research. Cancer Epidemiol Biomarkers Prev. 2015 Dec; 24(12):1811-9.
    View on PubMed
  5. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med. 2015 Jun 25; 372(26):2499-508.
    View on PubMed
  6. DNA Methylation in Whole Blood: Uses and Challenges. Curr Environ Health Rep. 2015 Jun; 2(2):145-54.
    View on PubMed
  7. Telomere maintenance and the etiology of adult glioma. Neuro Oncol. 2015 May 25.
    View on PubMed
  8. Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. Science. 2015 May 29; 348(6238):1036-9.
    View on PubMed
  9. CDKN2A Loss Is Associated With Shortened Overall Survival in Lower-Grade (World Health Organization Grades II-III) Astrocytomas. J Neuropathol Exp Neurol. 2015 May; 74(5):442-52.
    View on PubMed
  10. CHRNA5 Risk Variant Predicts Delayed Smoking Cessation and Earlier Lung Cancer Diagnosis-A Meta-Analysis. J Natl Cancer Inst. 2015 May; 107(5).
    View on PubMed
  11. Cell-composition effects in the analysis of DNA methylation array data: a mathematical perspective. BMC Bioinformatics. 2015; 16(1):95.
    View on PubMed
  12. Characterization of large structural genetic mosaicism in human autosomes. Am J Hum Genet. 2015 Mar 5; 96(3):487-97.
    View on PubMed
  13. Epigenetic remodeling in B-cell acute lymphoblastic leukemia occurs in two tracks and employs embryonic stem cell-like signatures. Nucleic Acids Res. 2015 Mar 11; 43(5):2590-602.
    View on PubMed
  14. Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time. Int J Cancer. 2015 Aug 15; 137(4):826-36.
    View on PubMed
  15. A steroid metabolizing gene variant in a polyfactorial model improves risk prediction in a high incidence breast cancer population. BBA Clin. 2014 Dec; 2:94-102.
    View on PubMed
  16. A comparison of DNA methylation specific droplet digital PCR (ddPCR) and real time qPCR with flow cytometry in characterizing human T cells in peripheral blood. Epigenetics. 2014 Oct 3; 9(10):1360-5.
    View on PubMed
  17. Genome-wide scan of 29,141 African Americans finds no evidence of directional selection since admixture. Am J Hum Genet. 2014 Oct 2; 95(4):437-44.
    View on PubMed
  18. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum Mol Genet. 2014 Dec 15; 23(24):6616-33.
    View on PubMed
  19. Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk. Nat Genet. 2014 Jul; 46(7):731-5.
    View on PubMed
  20. Leukocyte-adjusted epigenome-wide association studies of blood from solid tumor patients. Epigenetics. 2014 Jun; 9(6):884-95.
    View on PubMed

Go to UCSF Profiles, powered by CTSI